This announcement is a separate document:
泰格醫藥：(1)關於終止實施2022年A股限制性股票激勵計劃並作廢限制性股票；(2)建議註銷回購股份兼變更本公司註冊資本；(3)以集中競價方式回購A股股份方案；及(4)臨時股東大會通告及H股類別股東會議通告
TIGERMED: (1) TERMINATION OF IMPLEMENTATION OF 2022 RESTRICTED A SHARE INCENTIVE SCHEME AND LAPSE OF RESTRICTED SHARES; (2) PROPOSED CANCELLATION OF REPURCHASED SHARES AND CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; (3) REPURCHASE OF A SHARES THROUGH CENTRALIZE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.